ArticleArthritis research & therapy2014

Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacy.

Thasia G Woodworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.